← The Wire
VSTMNasdaq
Verastem, Inc.
Pharmaceutical Preparations · MA · CIK 1526119
Develops and commercializes medicines for RAS/MAPK pathway-driven cancers, including AVMAPKI FAKZYNJA CO-PACK
$360M
Market cap
$3.82
Last close
+1.1%
1D
-10.1%
5D
2.7M
Volume
Price · last 39 sessions-35.8%
May 4L $3.45 · H $6.01Jun 29
279
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 23, 20268-KReg FD Disclosure · Company UpdateJun 17, 20268-KShareholder VoteMay 26, 20268-KReg FD DisclosureMay 7, 20268-KReg FD DisclosureMar 4, 20268-KResults of Operations · Reg FD DisclosureFeb 4, 20268-KReg FD DisclosureJan 8, 20268-KReg FD Disclosure · Company UpdateDec 31, 20258-KExecutive Change · Reg FD DisclosureDec 19, 20258-KCompany UpdateNov 17, 20258-KResults of Operations · Reg FD DisclosureNov 4, 20258-KReg FD Disclosure · Company UpdateOct 23, 20258-KReg FD Disclosure · Company UpdateOct 20, 20258-KReg FD DisclosureSep 8, 20258-KReg FD Disclosure · Company UpdateAug 13, 20258-KReg FD DisclosureJun 2, 20258-KReg FD Disclosure · Company UpdateJun 2, 20258-KShareholder Vote · Reg FD DisclosureMay 23, 20258-KReg FD Disclosure · Company UpdateMay 8, 20258-KMaterial Agreement · Equity IssuanceApr 25, 20258-KReg FD DisclosureMar 20, 20258-KReg FD Disclosure · Company UpdateJan 23, 20258-KExecutive ChangeJan 21, 20258-KMaterial Agreement · Agreement TerminatedJan 13, 20258-KReg FD Disclosure · Company UpdateOct 17, 20248-KCompany UpdateJul 25, 20248-KCompany UpdateJul 23, 20248-KReg FD DisclosureJun 26, 20248-KReg FD Disclosure · Company UpdateMay 24, 20248-KShareholder Vote · Reg FD DisclosureMay 23, 20248-KReg FD DisclosureApr 9, 20248-KReg FD DisclosureJan 29, 20248-KShareholder VoteJan 19, 20248-KMaterial Agreement · New Debt / ObligationJan 8, 20248-KExecutive ChangeOct 27, 20238-KReg FD DisclosureSep 28, 20238-KReg FD DisclosureSep 12, 20238-KExecutive ChangeAug 4, 20238-KExecutive Change · Company UpdateJul 12, 20238-KCompany UpdateJun 21, 20238-KReg FD DisclosureJun 8, 20238-KSecurity-Holder Rights · Bylaw AmendmentMay 31, 20238-KCompany UpdateMay 25, 20238-KShareholder VoteMay 16, 20238-KNew Debt / ObligationMar 27, 20238-KReg FD DisclosureMar 13, 20238-KResults of OperationsFeb 2, 20238-KMaterial Agreement · Equity IssuanceJan 25, 20238-KReg FD DisclosureJan 24, 20238-KExecutive ChangeDec 15, 20228-KDelisting NoticeNov 9, 20228-KEquity Issuance · Bylaw AmendmentNov 7, 20228-KExecutive ChangeOct 20, 20228-KReg FD DisclosureOct 4, 20228-KExecutive ChangeSep 30, 20228-KResults of OperationsAug 8, 20228-KReg FD Disclosure · Company UpdateJun 6, 20228-KShareholder VoteMay 16, 20228-KMaterial AgreementMar 30, 20228-KExecutive Change · Material AgreementMar 28, 20228-KReg FD Disclosure · Company UpdateJan 11, 20228-KExecutive ChangeOct 26, 20218-KExecutive ChangeJun 24, 20218-KReg FD DisclosureMay 26, 20218-KShareholder VoteMay 20, 20218-KReg FD DisclosureFeb 25, 20218-KReg FD DisclosureDec 17, 20208-KAcquisition / Disposition · Reg FD DisclosureSep 30, 20208-KReg FD DisclosureSep 16, 20208-KExecutive ChangeAug 13, 20208-KMaterial Agreement · Results of OperationsAug 10, 20208-KBylaw Amendment · Shareholder VoteMay 21, 20208-KResults of Operations · Reg FD DisclosureApr 27, 20208-KExecutive ChangeApr 23, 20208-KExecutive ChangeApr 8, 20208-KMaterial Agreement · Results of OperationsFeb 28, 20208-KMaterial Agreement · Reg FD DisclosureJan 13, 20208-KMaterial Agreement · New Debt / ObligationNov 20, 20198-KMaterial Agreement · New Debt / ObligationNov 12, 20198-KResults of Operations · Exit / Disposal CostsOct 29, 2019
Insider Activity
In the 90 days to Feb 4, 2026: 6 sold $563K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | Paterson DanPresident and CEO | Sell | 970 | $6.69 | $6K |
| Jan 12, 2026 | Paterson DanPresident and CEO | Sell | 10,321 | $7.16 | $74K |
| Jan 12, 2026 | Calkins DanielChief Financial Officer | Sell | 5,039 | $7.16 | $36K |
| Dec 24, 2025 | Calkins DanielChief Financial Officer | Sell | 80 | $7.86 | $629 |
| Dec 16, 2025 | Stuglik Brian MDirector | Sell | 592 | $9.14 | $5K |
| Dec 16, 2025 | Paterson DanPresident and CEO | Sell | 393 | $9.14 | $4K |
| Dec 16, 2025 | Gagnon Robert E.Director | Sell | 283 | $9.14 | $3K |
| Dec 11, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 10, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.07 | $20K |
| Dec 9, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.25 | $21K |
| Dec 8, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.50 | $21K |
| Dec 5, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.61 | $21K |
| Dec 4, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 3, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Dec 2, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.32 | $21K |
| Dec 1, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.39 | $21K |
| Nov 28, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.79 | $22K |
| Nov 26, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.32 | $21K |
| Nov 25, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
| Nov 24, 2025 | Paterson DanPresident and CEO | Sell | 2,000 | $10.00 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance